RECOFOL ® propofol satisfying anaesthesia & ICU sedation
RECOFOL – 1st branded generic propofol acquired from Bayer in 2011
- intravenous anaesthetic, which is used by intensive care units, surgeries and clinics. RECOFOL can be used from light sedation to total anaesthesia
- RECOFOL active ingredient is propofol, which is the most widely used intravenous anaesthetic with growing global demand
- Primex are expanding RECOFOL geographically with regional partners
Recofol N is a Bayer-originated intravenous anaesthetic, which is used by intensive care units, surgeries and clinics.
Primex Pharmaceuticals obtained Recofol N through an acquisition from Bayer in 2012. Recofol N’s active ingredient is propofol.
Recofol N is manufactured in Europe.
Recofol EDTA (propofol plus EDTA) is propofol with the preservative EDTA as an antimicrobial retardant, as required by the FDA and other authorities and is manufactured in EU.